Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that the Investor Meeting with ‘Incred Capital’ will be held on Tuesday 28 February, 2023 in person. No Unpublished Price Sensitive Information will be shared during the meeting.
The above information is a part of company’s filings submitted to BSE.